BOD Science Ltd (BOD) - Net Assets

Latest as of June 2025: AU$-5.15 Million AUD ≈ $-3.65 Million USD

Based on the latest financial reports, BOD Science Ltd (BOD) has net assets worth AU$-5.15 Million AUD (≈ $-3.65 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$2.60 Million ≈ $1.84 Million USD) and total liabilities (AU$7.75 Million ≈ $5.48 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BOD financial resilience to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$-5.15 Million
% of Total Assets -198.44%
Annual Growth Rate N/A
5-Year Change -159.51%
10-Year Change N/A
Growth Volatility 79.69

BOD Science Ltd - Net Assets Trend (2016–2025)

This chart illustrates how BOD Science Ltd's net assets have evolved over time, based on quarterly financial data. Also explore BOD Science Ltd balance sheet assets for the complete picture of this company's asset base.

Annual Net Assets for BOD Science Ltd (2016–2025)

The table below shows the annual net assets of BOD Science Ltd from 2016 to 2025. For live valuation and market cap data, see BOD company net worth.

Year Net Assets Change
2025-06-30 AU$-5.15 Million
≈ $-3.65 Million		 +3.09%
2024-06-30 AU$-5.32 Million
≈ $-3.76 Million		 -656.10%
2023-06-30 AU$-703.36K
≈ $-497.67K		 -120.29%
2022-06-30 AU$3.47 Million
≈ $2.45 Million		 -59.97%
2021-06-30 AU$8.66 Million
≈ $6.13 Million		 +80.16%
2020-06-30 AU$4.81 Million
≈ $3.40 Million		 +132.61%
2019-06-30 AU$2.07 Million
≈ $1.46 Million		 -21.09%
2018-06-30 AU$2.62 Million
≈ $1.85 Million		 -12.73%
2017-06-30 AU$3.00 Million
≈ $2.12 Million		 -45.67%
2016-06-30 AU$5.52 Million
≈ $3.91 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to BOD Science Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 3984090600.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Common Stock AU$34.75 Million %
Other Comprehensive Income AU$720.90K %
Total Equity AU$-5.15 Million 100.00%

BOD Science Ltd Competitors by Market Cap

The table below lists competitors of BOD Science Ltd ranked by their market capitalization.

Company Market Cap
District Copper Corp
V:DCOP
 $3.02 Million
Vaxtex Cotfab Limited
NSE:VCL
 $3.02 Million
Engineer Gold Mines Ltd
V:EAU
 $3.02 Million
Kumho Industrial Co Ltd
KO:002995
 $3.02 Million
Plaza Centers NV
WAR:PLZ
 $3.01 Million
Photocat AS
ST:PCAT
 $3.01 Million
Datadot Technology Ltd
AU:DDT
 $3.01 Million
NORTHERN SHIELD RES INC.
F:N9SA
 $3.01 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in BOD Science Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -5,318,148 to -5,153,919, a change of 164,229.
  • Net income of 258,977 contributed positively to equity growth.
  • Other comprehensive income decreased equity by 238,561.
  • Other factors increased equity by 143,813.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$258.98K +5.02%
Other Comprehensive Income AU$-238.56K -4.63%
Other Changes AU$143.81K +2.79%
Total Change AU$- %

Book Value vs Market Value Analysis

This analysis compares BOD Science Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2016-06-30 AU$0.39 AU$0.02 x
2017-06-30 AU$0.09 AU$0.02 x
2018-06-30 AU$0.05 AU$0.02 x
2019-06-30 AU$0.03 AU$0.02 x
2020-06-30 AU$0.05 AU$0.02 x
2021-06-30 AU$0.09 AU$0.02 x
2022-06-30 AU$0.03 AU$0.02 x
2023-06-30 AU$0.00 AU$0.02 x
2024-06-30 AU$-0.03 AU$0.02 x
2025-06-30 AU$-0.03 AU$0.02 x

Capital Efficiency Dashboard

This dashboard shows how efficiently BOD Science Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 7.77%
  • • Asset Turnover: 1.28x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-92.49%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 -5.14% -205.63% 0.02x 1.02x AU$-836.15K
2017 -105.59% -897.94% 0.10x 1.20x AU$-3.47 Million
2018 -140.23% -430.60% 0.22x 1.46x AU$-3.93 Million
2019 -368.90% -929.45% 0.23x 1.69x AU$-7.83 Million
2020 -100.25% -96.11% 0.56x 1.85x AU$-5.30 Million
2021 -48.80% -64.24% 0.64x 1.20x AU$-5.09 Million
2022 -155.95% -157.87% 0.64x 1.53x AU$-5.75 Million
2023 0.00% -462.88% 0.49x 0.00x AU$-7.88 Million
2024 0.00% -732.44% 0.38x 0.00x AU$-5.88 Million
2025 0.00% 7.77% 1.28x 0.00x AU$774.37K

Industry Comparison

This section compares BOD Science Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $37,195,578
  • Average return on equity (ROE) among peers: -33.10%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
BOD Science Ltd (BOD) AU$-5.15 Million -5.14% N/A $3.01 Million
Althea Group Holdings Ltd (AGH) $-574.00K 0.00% 0.00x $12.05 Million
BPH Global Ltd (BP8) $4.72 Million -74.95% 0.62x $2.62 Million
Cann Group Ltd (CAN) $59.26 Million -57.02% 1.18x $5.62 Million
ECS Botanics Holdings Ltd (ECS) $1.50 Million -98.58% 0.21x $5.65 Million
Ecofibre Ltd (EOF) $109.94 Million -13.34% 0.36x $5.36 Million
Epsilon Healthcare Ltd (EPN) $28.09 Million -30.66% 0.17x $5.51 Million
Elixinol Wellness Ltd (EXL) $99.42 Million 0.00% 0.04x $2.05 Million
IDT Australia Ltd (IDT) $27.61 Million 7.62% 0.24x $12.10 Million
Invion Ltd (IVX) $4.79 Million -30.96% 0.18x $3.76 Million

About BOD Science Ltd

AU:BOD Australia Drug Manufacturers - Specialty & Generic
Market Cap
$3.01 Million
AU$4.26 Million AUD
Market Cap Rank
#29205 Global
#1704 in Australia
Share Price
AU$0.02
Change (1 day)
+0.00%
52-Week Range
AU$0.02 - AU$0.02
All Time High
AU$0.67
Categories
Companies in Australia Drug Manufacturers - Specialty & Generic Cannabis & CBD
About

Bod Science Limited operates as a cannabis focused drug development and product innovation company in Australia, the United Kingdom, the European Union, and the United States. The company operates through four segments: Medical, Over The Counter (OTC) Cannabidiol/Hemp, OTC Herbals, and Corporate. It engages in the development of cannabidiol and hemp products for consumers; and development and dis… Read more